Federated Hermes, Inc. Precigen, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $1 - $3	-1 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $3 - $5	1 New	1 $1,000
Q4 2020 Feb 12, 2021	SELL	$3.75 - $10.56 $858 - $2,418	-229 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.5 - $6.2 $24 - $43	-7 Reduced 2.97%	229 $1,000
Q2 2020 Aug 13, 2020	SELL	$2.16 - $5.46 $34 - $87	-16 Reduced 6.35%	236 $1,000
Q1 2020 May 13, 2020	BUY	$1.46 - $7.19 $367 - $1,811	252 New	252 $1,000

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $373M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.